The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Interleukin-1β-Induced Insulin Resistance in Adipocytes through Down-Regulation of Insulin Receptor Substrate-1 Expression
Open accessAbstract
Inflammation is associated with obesity and insulin resistance. Proinflammatory cytokines produced by adipose tissue in obesity could alter insulin signaling and action. Recent studies have shown a relationship between IL-1β level and metabolic syndrome or type 2 diabetes. However, the ability of IL-1β to alter insulin signaling and action remains to be explored. We demonstrated that IL-1β slightly increased Glut 1 translocation and basal glucose uptake in 3T3-L1 adipocytes. Importantly, we found that prolonged IL-1β treatment reduced the insulin-induced glucose uptake, whereas an acute treatment had no effect. Chronic treatment with IL-1β slightly decreased the expression of Glut 4 and markedly inhibited its translocation to the plasma membrane in response to insulin. This inhibitory effect was due to a decrease in the amount of insulin receptor substrate (IRS)-1 but not IRS-2 expression in both 3T3-L1 and human adipocytes. The decrease in IRS-1 amount resulted in a reduction in its tyrosine phosphorylation and the alteration of insulin-induced protein kinase B activation and AS160 phosphorylation. Pharmacological inhibition of ERK totally inhibited IL-1β-induced down-regulation of IRS-1 mRNA. Moreover, IRS-1 protein expression and insulin-induced protein kinase B activation, AS160 phosphorylation, and Glut 4 translocation were partially recovered after treatment with the ERK inhibitor. These results demonstrate that IL-1β reduces IRS-1 expression at a transcriptional level through a mechanism that is ERK dependent and at a posttranscriptional level independently of ERK activation. By targeting IRS-1, IL-1β is capable of impairing insulin signaling and action, and could thus participate in concert with other cytokines, in the development of insulin resistance in adipocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Kim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes
Spranger, J., Kroke, A., Möhlig, M., Hoffmann, K., Bergmann, M. M., Ristow, M., Boeing, H., & Pfeiffer, A. F. H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.812 · Cited by 1,493
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Rotter, V., Nagaev, I., & Smith, U. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301977200 · Cited by 1,062
Insulin-stimulated Phosphorylation of a Rab GTPase-activating Protein Regulates GLUT4 Translocation
Sano, H., Kane, S., Sano, E., Mı̂inea, C. P., Asara, J. M., Lane, W. S., Garner, C. W., & Lienhard, G. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300063200 · Cited by 962
IRS proteins and the common path to diabetes
White, M. F. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00514.2001 · Cited by 925
Positive and negative regulation of insulin signaling through IRS-1 phosphorylation
Gual, P., Le Marchand-Brustel, Y., & Tanti, J.-F. (2005) · Biochimie · doi:10.1016/j.biochi.2004.10.019 · Cited by 912
Self-citationSOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
Rui, L., Yuan, M., Frantz, D., Shoelson, S., & White, M. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200444200 · Cited by 904
Ueki, K., Kondo, T., & Kahn, C. R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5434-5446.2004 · Cited by 686
Plomgaard, P., Bouzakri, K., Krogh-Madsen, R., Mittendorfer, B., Zierath, J. R., & Pedersen, B. K. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2939 · Cited by 627
SOCS-3 Is an Insulin-induced Negative Regulator of Insulin Signaling
Emanuelli, B., Peraldi, P., Filloux, C., Sawka-Verhelle, D., Hilton, D., & Van Obberghen, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.21.15985 · Cited by 468
Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family
Martin, M. U., & Wesche, H. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(02)00320-8 · Cited by 426
Haruta, T. (2000) · Molecular Endocrinology · doi:10.1210/me.14.6.783 · Cited by 419
Lagathu, C., Bastard, J.-P., Auclair, M., Maachi, M., Capeau, J., & Caron, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.013 · Cited by 385
Ozes, O. N., Akca, H., Mayo, L. D., Gustin, J. A., Maehama, T., Dixon, J. E., & Donner, D. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051042298 · Cited by 382
Bost, F., Aouadi, M., Caron, L., Even, P., Belmonte, N., Prot, M., Dani, C., Hofman, P., Pagès, G., Pouysségur, J., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.2.402 · Cited by 339
Self-citationLong-term treatment with interleukin-1β induces insulin resistance in murine and human adipocytes
Lagathu, C., Yvan-Charvet, L., Bastard, J.-P., Maachi, M., Quignard-Boulangé, A., Capeau, J., & Caron, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0335-z · Cited by 321
Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein
Eguez, L., Lee, A., Chavez, J. A., Miinea, C. P., Kane, S., Lienhard, G. E., & McGraw, T. E. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.09.005 · Cited by 315
Tanti, J. F., Grémeaux, T., van Obberghen, E., & Le Marchand-Brustel, Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37568-3 · Cited by 309
Self-citationBouzakri, K., Roques, M., Gual, P., Espinosa, S., Guebre-Egziabher, F., Riou, J.-P., Laville, M., Le Marchand-Brustel, Y., Tanti, J.-F., & Vidal, H. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1319 · Cited by 305
Self-citationInsulin resistance: a phosphorylation-based uncoupling of insulin signaling
Zick, Y. (2001) · Trends in Cell Biology · doi:10.1016/s0962-8924(01)02129-8 · Cited by 292
Previs, S. F., Withers, D. J., Ren, J.-M., White, M. F., & Shulman, G. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006490200 · Cited by 291
Salmenniemi, U., Ruotsalainen, E., Pihlajamäki, J., Vauhkonen, I., Kainulainen, S., Punnonen, K., Vanninen, E., & Laakso, M. (2004) · Circulation · doi:10.1161/01.cir.0000150391.38660.9b · Cited by 264
(2006) · doi:10.1016/j.tem.2006.01.005 · Cited by 256
Takano, A., Usui, I., Haruta, T., Kawahara, J., Uno, T., Iwata, M., & Kobayashi, M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5050-5062.2001 · Cited by 251
Enhanced Basal Activation of Mitogen-Activated Protein Kinases in Adipocytes From Type 2 Diabetes
Carlson, C. J., Koterski, S., Sciotti, R. J., Poccard, G. B., & Rondinone, C. M. (2003) · Diabetes · doi:10.2337/diabetes.52.3.634 · Cited by 225
Fujishiro, M., Gotoh, Y., Katagiri, H., Sakoda, H., Ogihara, T., Anai, M., Onishi, Y., Ono, H., Abe, M., Shojima, N., et al. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0131 · Cited by 184
Huang, C., Thirone, A. C. P., Huang, X., & Klip, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412317200 · Cited by 180
Tumour necrosis factor alpha: a key regulator of adipose tissue mass
Warne, J. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1770351 · Cited by 176
Gual, P., Grémeaux, T., Gonzalez, T., MARCHAND‐BRUSTEL, Y. L., & Tanti, J. (2003) · Diabetologia · doi:10.1007/s00125-003-1223-4 · Cited by 152
Self-citationEngelman, J. A., Berg, A. H., Lewis, R. Y., Lisanti, M. P., & Scherer, P. E. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.10.0542 · Cited by 143
Shi, H., Cave, B. J., Inouye, K., Bjørbæk, C., & Flier, J. S. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0841 · Cited by 122
Potashnik, R., Bloch-Damti, A., Bashan, N., & Rudich, A. (2003) · Diabetologia · doi:10.1007/s00125-003-1097-5 · Cited by 112
He, J., Usui, I., Ishizuka, K., Kanatani, Y., Hiratani, K., Iwata, M., Bukhari, A., Haruta, T., Sasaoka, T., & Kobayashi, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0107 · Cited by 112
Ohsumi, J., Sakakibara, S., Yamaguchi, J., Miyadai, K., Yoshioka, S., Fujiwara, T., Horikoshi, H., & Serizawa, N. (1994) · Endocrinology · doi:10.1210/endo.135.5.7956951 · Cited by 111
Juge-Aubry, C. E., Somm, E., Chicheportiche, R., Burger, D., Pernin, A., Pittet-Cuenod, B. M., Quinodoz, P., Giusti, V., Dayer, J., & Meier, C. A. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031219 · Cited by 108
The new concept of adipose tissue function
Hauner, H. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.09.016 · Cited by 105
Boisclair, Y. R., Wang, J., Shi, J., Hurst, K. R., & Ooi, G. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.3841 · Cited by 104
Gual, P., Gonzalez, T., Grémeaux, T., Barrès, R., MARCHAND‐BRUSTEL, Y. L., & Tanti, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212273200 · Cited by 81
Self-citationStimulation of interleukin-6 release by interleukin-1β from isolated human adipocytes
Flower, L., Gray, R. P., Pinkney, J. H., & Mohamed‐Ali, V. (2003) · Cytokine · doi:10.1016/s1043-4666(02)00495-7 · Cited by 77
Hernández, R., Teruel, T., de Álvaro, C., & Lorenzo, M. (2004) · Diabetologia · doi:10.1007/s00125-004-1503-7 · Cited by 64
Bouzakri, K., Karlsson, H., Vestergaard, H., Madsbad, S., Christiansen, E., & Zierath, J. R. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0796 · Cited by 57
The Rab4 effector Rabip4 plays a role in the endocytotic trafficking of Glut 4 in 3T3-L1 adipocytes
Mari, M. C., Monzo, P., Kaddai, V., Keslair, F., Gonzalez, T., MARCHAND‐BRUSTEL, Y. L., & Cormont, M. (2006) · Journal of Cell Science · doi:10.1242/jcs.02850 · Cited by 48
Self-citationEmanuelli, B., Glondu, M., Filloux, C., Peraldi, P., & OBBERGHEN, E. V. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s97 · Cited by 47
Molecular mechanisms of inflammation in obesity-linked insulin resistance
Marette, A. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802500 · Cited by 44
A Crk-II/TC10 Signaling Pathway Is Required For Osmotic Shock-stimulated Glucose Transport
Gual, P., Shigematsu, S., Kanzaki, M., Grémeaux, T., Gonzalez, T., Pessin, J. E., MARCHAND‐BRUSTEL, Y. L., & Tanti, J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203042200 · Cited by 33
Self-citationInduction of SOCS-3 is insufficient to confer IRS-1 protein degradation in 3T3-L1 adipocytes
He, F., & Stephens, J. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.142 · Cited by 15
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance
Vandanmagsar, B., Youm, Y.-H., Ravussin, A., Galgani, J. E., Stadler, K., Mynatt, R. L., Ravussin, E., Stephens, J. M., & Dixit, V. D. (2011) · Nature Medicine · doi:10.1038/nm.2279 · Cited by 2,655
Cornier, M.-A., Dabelea, D., Hernandez, T. L., Lindstrom, R. C., Steig, A. J., Stob, N. R., Van Pelt, R. E., Wang, H., & Eckel, R. H. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0024 · Cited by 2,162
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Fatty acid–induced NLRP3-ASC inflammasome activation interferes with insulin signaling
Wen, H., Gris, D., Lei, Y., Jha, S., Zhang, L., Huang, M. T.-H., Brickey, W. J., & Ting, J. P.-Y. (2011) · Nature Immunology · doi:10.1038/ni.2022 · Cited by 1,698
Metadata
- Authors
- Jager, J., Grémeaux, T., Cormont, M., Le Marchand-Brustel, Y., & Tanti, J.-F.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2007-01-01
- Volume
- 148
- Issue
- 1
- Pages
- 241-251
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2112620654
- Cited by
- 695
- References
- 53
- FWCI
- 14.61
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.